Human Immunoglobulins
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
National Center for Research Resources (NCRR)other_biologicalPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
16 Active assets in the Chronic Inflammatory Demyelinating Polyradiculoneuropathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
AMIFAMPRIDINE National Center for Research Resources (NCRR) | Phase 3 | BB |
i10e Laboratoire français de Fractionnement et de Biotechnologies | Phase 3 | B |
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Fred Hutchinson Cancer Center | Phase 2 | CCC |
Cytarabine Fred Hutchinson Cancer Center | Phase 2 | CCC |
MELPHALAN Fred Hutchinson Cancer Center | Phase 2 | CCC |
View all 18 →
Same molecule, other indications
Human Immunoglobulins is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →